| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/26/2004 | EP1421109A2 Non-mammalian gnrh analogs and uses thereof in regulation of fertility and pregnancy |
| 05/26/2004 | EP1421098A2 Surface proteins of streptococcus pyogenes |
| 05/26/2004 | EP1420814A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 05/26/2004 | EP1420631A1 Plant-derived resistance gene |
| 05/26/2004 | EP1289554A4 Immunotherapeutic method to prevent islet cell rejection |
| 05/26/2004 | EP1127142A4 Modulation of polypeptide display on modified filamentous phage |
| 05/26/2004 | EP0995121B1 C-peptide specific assay procedure |
| 05/26/2004 | EP0971741B1 Use of avian antibodies |
| 05/26/2004 | EP0969851B1 Immunomodulatory complex and use thereof in helicobacter diseases |
| 05/26/2004 | EP0888125B1 GLYCOSYLATED IgG ANTIBODIES |
| 05/26/2004 | EP0751781B1 Use of monoclonal antibodies or soluble oligomeric ligands in the manufacture of a medicament for the prevention or treatment of neoplastic disorders |
| 05/26/2004 | CN1500152A Nucleic acid vaccines for prevention of flavivirus infection |
| 05/26/2004 | CN1500097A Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 05/26/2004 | CN1499983A Remedies for infact chronic arthritis-relating diseases |
| 05/26/2004 | CN1498894A Variable region gene in heavy chain and light chain of anti Pgp monoclone antibody |
| 05/26/2004 | CN1151377C Method of diagnosing and treating epithelioma |
| 05/26/2004 | CN1151251C New human-phosphoguanosine reductase, its coding sequence and application |
| 05/26/2004 | CN1151174C Process for preparing antiglobulin of human lymphocyte |
| 05/26/2004 | CN1151172C Novel membrane proteine P76 of helicobacter pylori |
| 05/26/2004 | CN1151170C Isolated peptides derived from MAGE tumor rejection antigen precursops which complex with HLA-A2 molecules |
| 05/25/2004 | US6740747 Bovine VDJ cassette, BF1H1, suitable for antigenization |
| 05/25/2004 | US6740740 Process for isolating and purifying proteins and peptides from plant sources |
| 05/25/2004 | US6740739 Substitutional variants of APO-2 ligand |
| 05/25/2004 | US6740738 Antibodies binding to polypeptides encoded by the genes |
| 05/25/2004 | US6740737 Cardiovascular system associated protein kinase 2 (CSAPK-2) antibodies |
| 05/25/2004 | US6740522 Rank (receptor activator of neurotrophic factor-kappa b) ligand (rankl) polypeptides; immunoregulatory activity |
| 05/25/2004 | US6740520 Cytokine receptor and nucleic acids encoding the same |
| 05/25/2004 | US6740512 Eukaryotic neutral sphingomyelinase (nsmase); used in drugs and in diagnosis |
| 05/25/2004 | US6740494 Nuclear matrix protein fluid assay |
| 05/25/2004 | US6740304 Receptor binding conjugates |
| 05/21/2004 | WO2004042352A2 Substrates of n-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrates |
| 05/21/2004 | WO2004042064A2 Disorders of lipid metabolism |
| 05/21/2004 | WO2004042028A2 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas |
| 05/21/2004 | WO2004042017A2 Methods and compositions for increasing antibody production |
| 05/21/2004 | WO2004042009A2 Inhibition of il-17 production |
| 05/21/2004 | WO2004042005A2 Methods of preparing improved agents by coevolution |
| 05/21/2004 | WO2004041997A2 Immunotherapy regimens in hiv-infected patients |
| 05/21/2004 | WO2004041867A2 Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders |
| 05/21/2004 | WO2004041866A1 Conjugate composition comprising antibodies against cd40 or cd28 |
| 05/21/2004 | WO2004041865A2 Stabilized single domain antibodies |
| 05/21/2004 | WO2004041864A2 Passive hyperimmune antibody therapy in the treatment of anthrax |
| 05/21/2004 | WO2004041863A2 Single domain antibodies directed against interferon- gamma and uses therefor |
| 05/21/2004 | WO2004041862A2 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 05/21/2004 | WO2004041855A1 Peptides for preventing, diagnosing and treating animal and/or human leptospirosis |
| 05/21/2004 | WO2004041846A2 INDUCIBLE LIGAND FOR α1β1 INTEGRIN AND USES |
| 05/21/2004 | WO2004041310A1 Preparation of chemically well-defined carbohydrate dendrimer conjugates |
| 05/21/2004 | WO2004041299A1 Dc-sign blockers and their use for preventing or treating viral infections. |
| 05/21/2004 | WO2004041297A2 Modified cytokines for use in cancer therapy |
| 05/21/2004 | WO2004041212A2 Apkc isoforms in nervous system disorders and cancer |
| 05/21/2004 | WO2004041179A2 Scavenger receptor b1 (cla-1) targeting for the treatment of infection, sepsis and inflammation |
| 05/21/2004 | WO2004041172A2 Interferon antagonists useful for the treatment of interferon related diseases |
| 05/21/2004 | WO2004041155A2 Treatment and prevention of abnormal scar formation in keloids and other cutaneous or internal wounds or lesions |
| 05/21/2004 | WO2004041152A2 Antigenic targets of autoimmune sensorineural hearing loss (aisnhl) and development of tests fro diagnosis and management of aisnhl |
| 05/21/2004 | WO2004026326A3 Antigen uptake receptor for candida albicans on dendritic cells |
| 05/21/2004 | WO2004022770A9 Compositions and methods for synthesizing nucleic acids |
| 05/21/2004 | WO2004022769A3 Means of detecting neurodegenerative processes and applications of same |
| 05/21/2004 | WO2004022709A3 Epitope sequences |
| 05/21/2004 | WO2004009759A8 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 05/21/2004 | WO2003105757A3 Methods and compositions for milieu-dependent binding of a targeted agent to a target |
| 05/21/2004 | WO2003086451A8 Asthma-related anti-il-13 immunoglobulin derived proteins, compositions, methods and uses |
| 05/21/2004 | WO2003080105A3 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
| 05/21/2004 | WO2003072040A3 Administration of agents for the treatment of inflammation |
| 05/21/2004 | WO2003055440A8 Compositions and methods for the treatement of immune related diseases |
| 05/21/2004 | WO2003042362A8 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR |
| 05/21/2004 | WO2002102306A8 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy |
| 05/21/2004 | WO2002090932A3 Methods and reagents for identifying insulin response modulators and therapeutic uses therefor |
| 05/21/2004 | WO2002067862A3 Regulation of the ctl response by macrophage migration inhibitory factor |
| 05/21/2004 | WO2002061105A8 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 05/21/2004 | WO2002014467A8 Cng2b: a putative human cyclic nucleotide-gated ion channel |
| 05/21/2004 | WO2000058340A3 50 human secreted proteins |
| 05/21/2004 | WO2000032745A3 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 05/21/2004 | CA2543376A1 Interferon antagonists useful for the treatment of interferon related diseases |
| 05/21/2004 | CA2505326A1 Camelidae antibodies against immunoglobulin e and use thereof for the treatment of allergic disorders |
| 05/21/2004 | CA2505325A1 Stabilized single domain antibodies |
| 05/21/2004 | CA2505316A1 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 05/21/2004 | CA2504419A1 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas |
| 05/21/2004 | CA2504350A1 Apkc isoforms in nervous system disorders and cancer |
| 05/21/2004 | CA2504125A1 Inducible ligand for .alpha.1.beta.1 integrin and uses |
| 05/21/2004 | CA2501786A1 Inhibition of il-17 production |
| 05/21/2004 | CA2499300A1 Methods and compositions for increasing antibody production |
| 05/20/2004 | US20040097713 Antibodies specific for phosphorylated insulin receptor substrate-1/2 (Ser1101/Ser1149) and uses thereof |
| 05/20/2004 | US20040097712 Therapeutic human anti-IL1-R1 monoclonal antibody |
| 05/20/2004 | US20040097711 Chimeric monoclonal antibody for diagnosis, prevention and treatment of immunological, nervous system, developmental, muscle and cell proliferative disorders |
| 05/20/2004 | US20040097708 Comprises nucleotide sequences coding membrane protein associated with odor detection for use in biological pest control |
| 05/20/2004 | US20040097456 Using a cytokine for prophylaxis, therapy and diagnosis of skin related growth disorders in mammals |
| 05/20/2004 | US20040096990 Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
| 05/20/2004 | US20040096987 Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
| 05/20/2004 | US20040096973 Diagnosing and preventing microorganismal infections using iron-restricted conditions; genetic vaccines |
| 05/20/2004 | US20040096956 Trangenic cells for generation of immunoglobulins for detection, quantitation, purification and neutralization of antigens; therapeutic diagnostics |
| 05/20/2004 | US20040096939 Modifier of organelle metabolism |
| 05/20/2004 | US20040096936 Comprises nucleotide sequences coding fibroblast growth factor (FGF) for treating cardiac disorders; tissue engineering; tissue-targeted gene therapy |
| 05/20/2004 | US20040096935 Antibodies against interleukin-17 receptor like protein |
| 05/20/2004 | US20040096921 Human plasma hyaluronidase |
| 05/20/2004 | US20040096920 Using immunoglobulins specific for brain natriuretic peptide to diagnose, classify, stratify and prognose mortality rates in patients with congestive heart failure |
| 05/20/2004 | US20040096919 Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP |
| 05/20/2004 | US20040096918 Electrochemiluminescent enzyme immunoassay |
| 05/20/2004 | US20040096901 Chineric monocllonal antibody for treatment and prevention transplant rejection, psoriasis, inflammatory bowel, autoimmune and allergic disorders |
| 05/20/2004 | US20040096889 Compositions, organisms and methodologies employing a novel human kinase |
| 05/20/2004 | US20040096888 Comprises nucleotide sequences coding cyclin dependent kinase (PELOTA) for diagnosis, treatment, prognosis and prevention of cell proliferative, cardoivascular, inflammatory, arthritic disorders |
| 05/20/2004 | US20040096881 For prophylactics/diagnostics/therapeutics; endothelial nitric oxide synthase (eNOS) |